

Biostate AI is a biotechnology company dedicated to advancing human health through innovative generative AI technologies. Founded in 2023, the company specializes in scalable biodata analysis, offering services that enhance the efficiency and affordability of RNA sequencing and data interpretation.

OmicsWeb is a comprehensive platform designed to streamline the management and analysis of complex omics datasets, particularly RNA sequencing (RNA-seq) data. Developed by Biostate AI, OmicsWeb integrates data storage, automated analysis workflows, and AI-driven tools to facilitate efficient and insightful biological research. By providing a unified environment, it eliminates the fragmentation and complexity often associated with omics data workflows, enabling researchers to focus on scientific discovery without the burden of managing disparate systems.

Biostate AI's RNA-Seq Services offer comprehensive and cost-effective total RNA sequencing solutions, utilizing their proprietary Barcode-Integrated Reverse Transcription (BIRT) technology. This innovative approach enables the analysis of all RNA types, including both coding and non-coding RNAs, providing a more complete transcriptomic profile compared to traditional methods that focus primarily on messenger RNA. By integrating advanced bioinformatics tools, Biostate AI delivers actionable insights from RNA sequencing data, facilitating scientific discovery and accelerating research in various fields.
Biostate AI is a technology company specializing in the development of artificial intelligence solutions for the life sciences and healthcare sectors. The company focuses on leveraging advanced data analytics and machine learning to enhance drug discovery, clinical trials, and patient outcomes. Biostate AI aims to improve decision-making processes and operational efficiencies within the biopharmaceutical industry by providing innovative tools and insights derived from complex biological data.